Patent Assignment
Reel/Frame 042832/0349
Change of Name
Recorded: 2017-06-15
Pages: 4
Assignor
ISIS PHARMACEUTICALS, INC.
Executed: 2015-12-18
Assignee
IONIS PHARMACEUTICALS, INC.
2855 GAZELLE COURT, CARLSBAD, CALIFORNIA, 92010
Covered Properties
(10)
Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini
Compounds and Methods for Modulating Expression Apob
Modulation of STAT5 Expression
Modification of MYD88 Splicing Using Modified Oligonucleotides
Base Modified Bicyclic Nucleosides and Oligomeric Compounds Prepared Therefrom
Methods for Inhibiting Expression of Connective Tissue Growth Factor
Modulation of Factor 11 Expression
Compositions and Methods for Non-Parenteral Delivery of Oligonucleotides
Antibacterial 4,6-Substituted 6', 6'' and 1 Modified Aminoglycoside Analogs
Diagnosis and Treatment of Disease
Patent:
8,697,860 →
Application:
13/944,786 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 8, 2004
From: SWAYZA, ERIC E.; MIGAWA, MICHAEL T.; WYRZYKIEWICZ, TADEUSZ KRZYSZTOF
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 015347/0925 →
Assignment of Assignor's Interest
Jan 29, 2009
From: BHANOT, SANJAY; GEARY, RICHARD S.; MCKAY, ROBERT; MONIA, BRETT P.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 022175/0147 →
Assignment of Assignor's Interest
Nov 8, 2018
From: MONIA, BRETT P.; FREIER, SUSAN M.; SIWKOWSKI, ANDREW M.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 047457/0418 →
Assignment of Assignor's Interest
Nov 20, 2018
From: GUO, SHULING
To: IONIS PHARMACEUTICALS, INC.
Reel/Frame 047558/0123 →
Assignment of Assignor's Interest
Jan 3, 2022
From: DEAN, NICHOLAS M.; FOULKES, J. GORDON; O'DONNELL, NIALL
To: EXCALIARD PHARMACEUTICALS, INC.
Reel/Frame 058529/0980 →
Assignment of Assignor's Interest
Jan 3, 2022
From: BENNETT, C. FRANK; FREIER, SUSAN M.
To: ISIS PHARMACEUTICALS, INC.
Reel/Frame 058530/0014 →